American Banking and Market News logo

The Latest Headlines at American Banking and Market News

Image about Axsome Therapeutics, Inc. (NASDAQ:AXSM) Expected to Post Q1 2024 Earnings of ($1.26) Per Share

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Expected to Post Q1 2024 Earnings of ($1.26) Per Share

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) – Research analysts at William Blair raised their Q1 2024 earnings per share estimates for shares of Axsome Therapeutics in a research report issued on Wednesday,... More of this article »
Image about Q1 2024 EPS Estimates for argenx SE Increased by William Blair (NASDAQ:ARGX)

Q1 2024 EPS Estimates for argenx SE Increased by William Blair (NASDAQ:ARGX)

argenx SE (NASDAQ:ARGX – Free Report) – Investment analysts at William Blair increased their Q1 2024 earnings estimates for shares of argenx in a note issued to investors on Wednesday, April 17th. William Blair analyst... More of this article »
Image about William Blair Comments on Appian Co.’s Q1 2024 Earnings (NASDAQ:APPN)

William Blair Comments on Appian Co.’s Q1 2024 Earnings (NASDAQ:APPN)

Appian Co. (NASDAQ:APPN – Free Report) – Research analysts at William Blair increased their Q1 2024 earnings estimates for Appian in a research report issued to clients and investors on Wednesday, April 17th. William... More of this article »
Image about BCE Inc. Expected to Earn Q1 2024 Earnings of $0.51 Per Share (NYSE:BCE)

BCE Inc. Expected to Earn Q1 2024 Earnings of $0.51 Per Share (NYSE:BCE)

BCE Inc. (NYSE:BCE – Free Report) (TSE:BCE) – Stock analysts at Cormark issued their Q1 2024 earnings per share estimates for BCE in a research note issued on Thursday, April 18th. Cormark analyst D. Mcfadgen expects... More of this article »
Image about Q1 2024 EPS Estimates for Biogen Inc. (NASDAQ:BIIB) Cut by William Blair

Q1 2024 EPS Estimates for Biogen Inc. (NASDAQ:BIIB) Cut by William Blair

Biogen Inc. (NASDAQ:BIIB – Free Report) – Equities researchers at William Blair decreased their Q1 2024 earnings per share estimates for shares of Biogen in a report released on Wednesday, April 17th. William Blair... More of this article »
Image about Q1 2024 EPS Estimates for Biogen Inc. Reduced by Wedbush (NASDAQ:BIIB)

Q1 2024 EPS Estimates for Biogen Inc. Reduced by Wedbush (NASDAQ:BIIB)

Biogen Inc. (NASDAQ:BIIB – Free Report) – Research analysts at Wedbush dropped their Q1 2024 earnings per share estimates for Biogen in a report issued on Wednesday, April 17th. Wedbush analyst L. Chico now anticipates... More of this article »
Image about Q1 2024 EPS Estimates for Core Laboratories Inc. (NYSE:CLB) Cut by Analyst

Q1 2024 EPS Estimates for Core Laboratories Inc. (NYSE:CLB) Cut by Analyst

Core Laboratories Inc. (NYSE:CLB – Free Report) – Investment analysts at Zacks Research lowered their Q1 2024 earnings estimates for Core Laboratories in a research note issued on Thursday, April 18th. Zacks Research... More of this article »
Image about Q1 2024 EPS Estimates for Carlisle Companies Incorporated (NYSE:CSL) Lifted by Zacks Research

Q1 2024 EPS Estimates for Carlisle Companies Incorporated (NYSE:CSL) Lifted by Zacks Research

Carlisle Companies Incorporated (NYSE:CSL – Free Report) – Zacks Research increased their Q1 2024 earnings estimates for shares of Carlisle Companies in a note issued to investors on Thursday, April 18th. Zacks Research... More of this article »
Image about Edwards Lifesciences Co. (NYSE:EW) to Post Q1 2024 Earnings of $0.65 Per Share, Leerink Partnrs Forecasts

Edwards Lifesciences Co. (NYSE:EW) to Post Q1 2024 Earnings of $0.65 Per Share, Leerink Partnrs Forecasts

Edwards Lifesciences Co. (NYSE:EW – Free Report) – Stock analysts at Leerink Partnrs reduced their Q1 2024 EPS estimates for shares of Edwards Lifesciences in a research note issued on Wednesday, April 17th. Leerink... More of this article »
Image about Lantheus Holdings, Inc. to Post Q1 2024 Earnings of $1.47 Per Share, Leerink Partnrs Forecasts (NASDAQ:LNTH)

Lantheus Holdings, Inc. to Post Q1 2024 Earnings of $1.47 Per Share, Leerink Partnrs Forecasts (NASDAQ:LNTH)

Lantheus Holdings, Inc. (NASDAQ:LNTH – Free Report) – Investment analysts at Leerink Partnrs lowered their Q1 2024 earnings per share estimates for Lantheus in a note issued to investors on Wednesday, April 17th. Leerink... More of this article »
Image about Shopify Inc. (NYSE:SHOP) to Post Q1 2024 Earnings of $0.11 Per Share, National Bank Financial Forecasts

Shopify Inc. (NYSE:SHOP) to Post Q1 2024 Earnings of $0.11 Per Share, National Bank Financial Forecasts

Shopify Inc. (NYSE:SHOP – Free Report) (TSE:SHOP) – Stock analysts at National Bank Financial lifted their Q1 2024 earnings per share estimates for shares of Shopify in a research note issued on Wednesday, April 17th.... More of this article »
Image about DA Davidson Comments on First Foundation Inc.’s Q1 2024 Earnings (NASDAQ:FFWM)

DA Davidson Comments on First Foundation Inc.’s Q1 2024 Earnings (NASDAQ:FFWM)

First Foundation Inc. (NASDAQ:FFWM – Free Report) – DA Davidson boosted their Q1 2024 EPS estimates for shares of First Foundation in a research report issued on Wednesday, April 17th. DA Davidson analyst G. Tenner... More of this article »
Image about National Bank Financial Comments on Docebo Inc.’s Q1 2024 Earnings (NASDAQ:DCBO)

National Bank Financial Comments on Docebo Inc.’s Q1 2024 Earnings (NASDAQ:DCBO)

Docebo Inc. (NASDAQ:DCBO – Free Report) – Research analysts at National Bank Financial issued their Q1 2024 earnings estimates for Docebo in a report released on Wednesday, April 17th. National Bank Financial analyst... More of this article »
Image about Q1 2024 EPS Estimates for Stepan (NYSE:SCL) Increased by Seaport Res Ptn

Q1 2024 EPS Estimates for Stepan (NYSE:SCL) Increased by Seaport Res Ptn

Stepan (NYSE:SCL – Free Report) – Investment analysts at Seaport Res Ptn lifted their Q1 2024 earnings per share estimates for Stepan in a research report issued on Wednesday, April 17th. Seaport Res Ptn analyst M.... More of this article »
Image about Wedbush Weighs in on Sage Therapeutics, Inc.’s Q1 2024 Earnings (NASDAQ:SAGE)

Wedbush Weighs in on Sage Therapeutics, Inc.’s Q1 2024 Earnings (NASDAQ:SAGE)

Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Analysts at Wedbush reduced their Q1 2024 earnings estimates for Sage Therapeutics in a research note issued to investors on Wednesday, April 17th. Wedbush analyst... More of this article »